Glaucoma Treatment Market By Glaucoma Type (Open-Angle Glaucoma, Angle-Closure Glaucoma, Normal-Tension Glaucoma, and Others); By Medication (Alpha Adrenergic Agonists, Beta Blockers, Carbonic Anhydrase Inhibitors, Miotics, Prostaglandin Analogs, Combination Medication, and Others); By Route of Administration (Oral and Topical); By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); By Region (North America (U.S., Canada, Mexico, & Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden & Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), & Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore & Rest of Southeast Asia), & Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, & Rest of Middle East & Africa) Latin America (Brazil, Argentina, & Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029